AirSculpt Technologies, Inc. (AIRS)
USD 5.85
(-7.0%)
USD 5.85
(-7.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 213.55 Million USD | 6.37% |
| 2022 | 200.75 Million USD | 0.1% |
| 2021 | 200.55 Million USD | 11.66% |
| 2020 | 179.61 Million USD | 4.73% |
| 2019 | 171.5 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 210.11 Million USD | 3.65% |
| 2024 Q1 | 202.71 Million USD | -5.08% |
| 2023 Q4 | 213.55 Million USD | 4.62% |
| 2023 FY | 213.55 Million USD | 6.37% |
| 2023 Q2 | 217.28 Million USD | 3.71% |
| 2023 Q1 | 209.52 Million USD | 4.36% |
| 2023 Q3 | 204.12 Million USD | -6.06% |
| 2022 Q2 | 218.77 Million USD | 5.57% |
| 2022 Q1 | 207.22 Million USD | 3.33% |
| 2022 FY | 200.75 Million USD | 0.1% |
| 2022 Q4 | 200.75 Million USD | 3.53% |
| 2022 Q3 | 193.92 Million USD | -11.36% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 200.55 Million USD | 11.66% |
| 2021 Q2 | 185.3 Million USD | 0.0% |
| 2021 Q4 | 200.55 Million USD | 4.32% |
| 2021 Q3 | 192.24 Million USD | 3.75% |
| 2020 FY | 179.61 Million USD | 4.73% |
| 2020 Q4 | 179.61 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 171.5 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 96.015% |
| Addus HomeCare Corporation | 1.02 Billion USD | 79.154% |
| Amedisys, Inc. | 2.06 Billion USD | 89.634% |
| American Oncology Network, Inc. | 374.45 Million USD | 42.97% |
| Astrana Health, Inc. | 933.36 Million USD | 77.12% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 86.956% |
| IMAC Holdings, Inc. | 1.14 Million USD | -18565.191% |
| biote Corp. | 155.29 Million USD | -37.514% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -248.823% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 68.564% |
| COMPASS Pathways plc | 275.98 Million USD | 22.622% |
| DocGo Inc. | 490.45 Million USD | 56.458% |
| The Ensign Group, Inc. | 4.17 Billion USD | 94.888% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 73.412% |
| InnovAge Holding Corp. | 547.66 Million USD | 61.007% |
| Assure Holdings Corp. | 7.51 Million USD | -2742.055% |
| The Joint Corp. | 87.15 Million USD | -145.037% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 90.437% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -2585.981% |
| ModivCare Inc. | 1.76 Billion USD | 87.916% |
| NewGenIvf Group Limited | 1.64 Million USD | -12862.5% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -500.488% |
| Option Care Health, Inc. | 3.32 Billion USD | 93.584% |
| P3 Health Partners Inc. | 860.96 Million USD | 75.196% |
| P3 Health Partners Inc. | 860.96 Million USD | 75.196% |
| The Pennant Group, Inc. | 539.69 Million USD | 60.431% |
| Surgery Partners, Inc. | 7.01 Billion USD | 96.958% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -4237.593% |
| Talkspace, Inc. | 142.22 Million USD | -50.155% |
| Talkspace, Inc. | 142.22 Million USD | -50.155% |
| The Oncology Institute, Inc. | 219.41 Million USD | 2.673% |
| The Oncology Institute, Inc. | 219.41 Million USD | 2.673% |